Federated Hermes
ABVX

Federated Hermes’s Abivax ABVX Stock Holding History

Federated Hermes’s Portfolio ABVX Stock Details ABVX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$12M Hold
108,200
– – 0.02% 585
2025
Q4 		$14.6M Buy
108,200
+8,700
+9% +$949K 0.02% 528
2025
Q3 		$8.45M Buy
+99,500
New +$6.1M 0.01% 603

Other funds holding ABVX

TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
DGM
Darwin Global Management St. Helier, Jersey $3.77B AUM 307.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
VPC
Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return
CP
Caligan Partners New York $1.5B AUM 518.95% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $1.7B AUM 340.85% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
HI
Helikon Investments London, United Kingdom $2.65B AUM 79.03% 1-Year Est. Return

Federated Hermes's ABVX Position: Q1 2026 in Review

Federated Hermes held its Abivax (ABVX) position steady in Q1 2026 at 108,200 shares worth $12M. The position accounts for 0.02% of the portfolio, ranked #585.

Federated Hermes first reported a position in ABVX in Q3 2025 and has held it in 3 quarters since. The position peaked at $14.6M in Q4 2025. 254 funds tracked by Wall St. Rank hold ABVX as of Q1 2026.

  • Federated Hermes held 108,200 shares of Abivax worth $12M as of Q1 2026.
  • Federated Hermes left its Abivax share count unchanged in Q1 2026.
  • Abivax made up 0.02% of Federated Hermes's portfolio in Q1 2026, its #585 holding.
  • Federated Hermes first reported a position in Abivax in Q3 2025 and has held it in 3 quarters since.
  • Federated Hermes's Abivax position peaked at $14.6M in Q4 2025.
  • 254 funds tracked by Wall St. Rank held Abivax as of Q1 2026.

Based on Federated Hermes's 13F filing for Q1 2026, filed 11 May 2026.